Prepare for your visit

James A Fojt

Internal Medicine · Prosper, TX · NPI 1154340701

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$2,413.38

in general payments reported to CMS, 2019-2025 · $16.44 in 2025

The $16.44 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).

Who reported paying

General payments only, top 6 by amount.

Amarin Pharma, INC. $378.43
Amgen INC. $246.79
Boehringer Ingelheim Pharmaceuticals, INC. $221.79
Novo Nordisk INC $205.24
Corcept Therapeutics $187.88
Merck Sharp & Dohme LLC $133.11

Drugs and devices associated with these payments

Freestyle Libre 3 Korlym Repatha Quviviq Ozempic Vascepa Dexcom G6 Transmitter Shingrix Synthroid Otezla Rybelsus Ubrelvy

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw James Fojt listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/766268/james-a-fojt